Physician profile

Awad Javaid

Internal Medicine · Las Vegas, NV

NPI 1376084509

$10,984.90

in general payments reported to CMS, 2019-2025

33 companies · $6,067 in 2025

The $6,067 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,370.08
Travel and Lodging$1,298.82
Grant$1,126.44
Education$862.19

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $3,271.44 2021-2025 Xact, Perclose Proglide, Gallant
Boston Scientific Corporation $1,516.34 2022-2025 Watchman Flx, Watchman Access System, Eluvia
Aop Health US, LLC $886.20 2025 Rapiblyk
Biosense Webster, INC. $718.37 2023-2025 Carto 3, Nuvision Ice Catheter, Visitag Surpoint External Processing Unit
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $542.82 2021-2024 Lifevest
W. L. Gore & Associates, INC. $539.82 2025 Gore Viabahn Vbx Balloon Expandable Endo
Medtronic, INC. $533.86 2025 Abre, Hawkone, Symplicity G3
Cordis US Corp. $361.38 2025 Mynx Control Venous
Cardiva Medical, INC. $275.43 2025 Cardiva Vascade 5f Vcs, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f
Bard Peripheral Vascular, INC. $235.67 2025 Lifestream, Rotarexs 6 F X 135 Cm, Dorado
Lantheus Medical Imaging, INC. $211.22 2021-2024 Definity
Abiomed $187.24 2023-2025 Impella
Astellas Pharma US INC $183.99 2023
Novo Nordisk INC $182.20 2023-2024 Rybelsus, Ozempic
E.R. Squibb & Sons, L.L.C. $141.70 2022
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Imperative Care, INC $139.48 2025 Symphony Catheter
Janssen Pharmaceuticals, INC $134.92 2022
Astrazeneca Pharmaceuticals Lp $124.81 2023
Actelion Pharmaceuticals US, INC. $116.74 2022
Chiesi USA, INC. $109.88 2024-2025 Kengreal, Cleviprex
Asahi Intecc USA, INC. $106.41 2024 Peripheral Vascular
Penumbra, INC. $87.41 2025 Ruby Coil, Penumbra System
Merck Sharp & Dohme LLC $72.59 2021
Amgen INC. $43.99 2024-2025 Repatha, Repatha
Esperion Therapeutics, INC. $42.86 2021
Kestra Medical Technology Services, INC. $42.71 2025 Assure Wcd
Livanova USA, INC. $35.07 2022
Surmodics, INC. $30.95 2025 Pounce Venous Thrombectomy System, Pounce Thrombectomy
Cardiovascular Systems INC. $25.38 2022
Lexicon Pharmaceuticals, INC. $24.16 2024 Inpefa
Cook Medical LLC $22.52 2025 Cook Celect
Terumo Medical Corporation $19.88 2024 Angio-Seal
Celgene Corporation $17.46 2023 Zeposia

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Awad Javaid

$10,984.90

in general payments reported 2019-2025

Years
2021-2025
Top company
Abbott Laboratories
Context
The $6,067 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/7825019/awad-javaid

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.